Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Wall Street Opens Mixed; Covid Lockdown Fears Rise, Dow Falls 200 Pts

Published 2021-11-19, 09:48 a/m
Updated 2021-11-19, 09:48 a/m
© Reuters.

By Peter Nurse 

Investing.com -- U.S. stock markets opened mixed Friday, with the economically-stable tech sector outperforming after news of another Covid-driven lockdown in Europe weighed on sentiment. 

Earlier Friday, Austria announced plans to reimpose a full Covid-19 lockdown to combat soaring infections, becoming the first country in western Europe to reimpose such severe sanctions. Neighboring Germany warned it may follow suit, raising fears of another step backwards in global economic activity.

By 9:40 AM ET (1440 GMT), the Dow Jones Industrial Average was down 200 points, or 0.6% at 35,879 points. The S&P 500 was also down 0.1%, but the  Nasdaq Composite gained 0.4%, climbing to a new record high. 

Stocks of tech giants Alphabet (NASDAQ:GOOGL), Amazon.com (NASDAQ:AMZN) and Microsoft (NASDAQ:MSFT) headed higher Friday as investors sought out the safety of these financially strong companies, although Apple (NASDAQ:AAPL) underperformed following a report that the iPhone-maker may debut its electric car as soon as 2025.

On the flip side, stocks linked to the travel industry, like the airlines Delta (NYSE:DAL), United (NASDAQ:UAL) and American (NASDAQ:AAL) and the cruise operators, Norwegian (NYSE:NCLH) and Carnival (NYSE:CUK), were hit hard by the lockdown news. Additionally, oil firms Exxon Mobil (NYSE:XOM) and Chevron (NYSE:CVX) fell 2.1% and 1.8% as crude prices sank.

Elsewhere, Foot Locker (NYSE:FL) stock slumped almost 8% after the sports apparel retailer warned of global supply constraints heading into the busiest time of the year for retailers, while Workday (NASDAQ:WDAY) stock traded 6% lower amid valuation concerns over its proposal to buy VNDLY for over $500 million.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The pharmaceutical sector will also be in the spotlight after the U.S. Food and Drug Administration authorized booster doses of Covid-19 vaccines for all adults who were vaccinated with either the Moderna (NASDAQ:MRNA) drug and the shot developed by Pfizer (NYSE:PFE) and partner BioNTech.

In other news, the U.S. House of Representatives will vote on President Joe Biden's $1.75 trillion social spending bill on Friday. If the measure passes, it would still need approval in the Senate before Biden could sign it into law. 

Additionally, Federal Reserve policymakers Richard Clarida and Christopher Waller are due to speak Friday, with investors looking for signs of increased concern at the surging inflation levels in the economy, as this could point to a speeding up of the central bank’s tapering process.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.